Stay updated on Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page.

Latest updates to the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page
- Check5 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the previous visible content and indicating that the study page is currently restricted or unavailable.SummaryDifference0.5%

- Check12 days agoChange DetectedThe page now displays a 403 Forbidden error page instead of the study content, with the site chrome and a Home button visible. This indicates the trial record is currently inaccessible due to access restrictions.SummaryDifference18%

- Check19 days agoChange DetectedThe Revision label on the page was updated to v3.7.0, replacing the previous v3.6.6. This indicates a new page version without modifying study content.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page version was updated from v3.6.5 to v3.6.6, indicating a small internal update to the page template. The visible study information remains unchanged.SummaryDifference0.0%

- Check40 days agoChange DetectedA funding attribution entry was added to the study record: '2014 ( U.S. NIH Grant/Contract )' under the list of Other Study ID Numbers. This addition provides the NIH funding source for the trial as background information.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, representing a newer version of the site template or page metadata.SummaryDifference0.0%

Stay in the know with updates to Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page.